 with type 2 diabetes, but outside of that condition, you have no other health issues. Should you take a newer class of diabetes medicine, or will one of the older ones serve you just as well? That's one issue with a new meta-analysis of diabetes medicines, says Johns Hopkins diabetes expert Rita Kalyani. As someone who has spent a lot of time looking at these trials, it is important to recognize that these trials specifically involve